ALBUTROPIN Trademark

Trademark Overview

On Thursday, January 15, 2009, a trademark application was filed for ALBUTROPIN with the United States Patent and Trademark Office. The USPTO has given the ALBUTROPIN trademark a serial number of 77649883. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 4, 2013. This trademark is owned by Human Genome Sciences, Inc.. The ALBUTROPIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, fusion protein for treatment of growth hormone deficiency
albutropin

General Information

Serial Number77649883
Word MarkALBUTROPIN
Filing DateThursday, January 15, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 4, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, fusion protein for treatment of growth hormone deficiency
Translation of Words in MarkThe wording "Albutropin" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 21, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressBRENTFORD MIDDLESEX TW8 9GS
GB
Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Wednesday, May 28, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 4, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 4, 2013ABANDONMENT - NO USE STATEMENT FILED
Friday, October 5, 2012ASSIGNED TO EXAMINER
Saturday, July 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 27, 2012EXTENSION 5 GRANTED
Thursday, July 26, 2012EXTENSION 5 FILED
Thursday, July 26, 2012TEAS EXTENSION RECEIVED
Tuesday, January 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2012EXTENSION 4 GRANTED
Wednesday, January 25, 2012EXTENSION 4 FILED
Wednesday, January 25, 2012TEAS EXTENSION RECEIVED
Friday, July 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 7, 2011EXTENSION 3 GRANTED
Wednesday, July 6, 2011EXTENSION 3 FILED
Wednesday, July 6, 2011TEAS EXTENSION RECEIVED
Thursday, February 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2011EXTENSION 2 GRANTED
Friday, January 28, 2011EXTENSION 2 FILED
Wednesday, February 16, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 28, 2011TEAS EXTENSION RECEIVED
Wednesday, October 13, 2010ASSIGNED TO EXAMINER
Thursday, July 15, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 13, 2010EXTENSION 1 GRANTED
Tuesday, July 13, 2010EXTENSION 1 FILED
Tuesday, July 13, 2010TEAS EXTENSION RECEIVED
Tuesday, February 2, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 10, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2009PUBLISHED FOR OPPOSITION
Thursday, October 8, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, October 6, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 6, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, October 6, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, October 6, 2009EXAMINERS AMENDMENT -WRITTEN
Friday, September 25, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 25, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 25, 2009ASSIGNED TO LIE
Wednesday, September 23, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 31, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2009NON-FINAL ACTION E-MAILED
Tuesday, March 31, 2009NON-FINAL ACTION WRITTEN
Friday, March 27, 2009ASSIGNED TO EXAMINER
Wednesday, January 21, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

albutropin growth hormone deficiency treatment protein preparations namely fusion pharmaceutical